or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    AVGO C 1.90 6.58
    LLY D 0.75 5.77
    ABBV A -0.07 4.53
    MRK F -2.32 4.25
    MDLZ C -0.97 3.57
    PEP D -1.07 3.54
    PG C -0.65 3.30
    NEE A 0.19 3.19
    WMB A 2.76 3.02
    MMC D 0.13 2.95

    Represented by ETF Holdings

    Keywords: S&P 500 Nasdaq 100 Animal Health Animal Health Products Antibiotics Cheese Constipation Depressive Disorder Diabetes Dow Jones Component Health Products Milk Natural Gas Obesity Pharmaceutical Products Snack Food Telecommunications Adalimumab Advanced Prostate Cancer Alternative Energy
    Industries: Drug Manufacturers - Major Beverages - Soft Drinks Confectioners Household & Personal Products Insurance Brokers Oil & Gas Midstream Semiconductors Utilities - Regulated Electric

    Recent News for ETF Series Solutions Bahl & Gaynor Income Growth ETF & its Holdings

    Date Stock Title
    Oct 2 AVGO Better AI Chipmaker Stock: Broadcom vs. Qualcomm
    Oct 2 LLY Jim Cramer Remains Steadfast On Eli Lilly and Company (NYSE:LLY)
    Oct 2 NEE Top Analyst Reports for NextEra Energy, Lockheed Martin & Palo Alto Networks
    Oct 2 LLY Eli Lilly to Invest $4.5 Billion to Open New Drug Manufacturing, Development Center
    Oct 2 PEP PepsiCo to Buy Siete in a $1.2B Deal: Will it Boost the Stock?
    Oct 2 AVGO Why auto industry woes are dragging down chip stocks
    Oct 2 PEP Why Celsius Holdings Stock Fell 18% in September
    Oct 2 LLY Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements
    Oct 2 LLY Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock
    Oct 2 AVGO William Blair Initiates Outperform Rating on Broadcom Inc. (AVGO), Citing $12 Billion AI Revenue Target for FY 2024
    Oct 2 LLY Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
    Oct 2 WMB S&P 500 Energy ends Q3 on negative note as crude prices fall
    Oct 2 LLY Eli Lilly Building $4.5B Pharmaceutical Factory in Indiana
    Oct 2 ABBV AbbVie: $200 Peak (Rating Downgrade)
    Oct 2 LLY Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn’t a Problem.
    Oct 2 AVGO Brokers Suggest Investing in Broadcom Inc. (AVGO): Read This Before Placing a Bet
    Oct 2 LLY Eli Lilly Plans $4.5 Billion Research Hub
    Oct 2 NEE How to protect your investments in unstable markets
    Oct 2 PG How to protect your investments in unstable markets
    Oct 2 ABBV AbbVie's Skyrizi And Rinvoq Deserve The Premium Growth Valuation
    The fund is an actively managed exchange-traded fund ("ETF") that invests primarily in dividend-paying U.S.-listed equity securities of large capitalization companies, predominately those with a market capitalization greater than $7 billion.
    Exchange Traded Funds SPDR Stock Fund Dividend
    Back to the Main BGIG Page...